1h Free Analyst Time
The Atrial Fibrillation Surgery Market size was estimated at USD 2.67 billion in 2023, USD 2.90 billion in 2024, and is expected to grow at a CAGR of 9.00% to reach USD 4.88 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Atrial fibrillation surgery is a medical procedure to treat atrial fibrillation (AFib), an irregular and often rapid heart rate that can lead to poor blood flow, stroke, and other cardiovascular complications. Major types of atrial fibrillation surgeries include catheter ablation, surgical ablation, and left atrial appendage closure (LAAC). Over the years, there has been a significant prevalence of chronic diseases such as diabetes and hypertension, which are key risk factors for developing AFib; as a result, demand for effective AFib treatment options has surged. Innovations in minimally invasive techniques, such as catheter ablation, have significantly improved patient outcomes while reducing recovery time. However, product recalls associated with AFib surgical products, limited reimbursements for surgeries, and limited availability of surgeons to conduct the procedure also impact the market. Market players are creating affordable devices or techniques that enable greater accessibility to life-saving treatments for patients across different socioeconomic backgrounds. Continued research in areas such as artificial intelligence, robotics, and bioelectronic medicine is expected to lead to the development of innovative AFib surgery solutions that further improve patient outcomes and minimize complications.
Regional Insights
North America's atrial fibrillation surgery market observes an advancing landscape driven by the well-established healthcare infrastructure and favorable reimbursement policies to conduct surgical procedures. There have been several innovative medication products and devices approved by the U.S. Food & Drug Administration (FDA) and Health Canada in the region, portraying an improved development scenario. In Asia-Pacific, countries such as India, Japan, and China have seen a rapid increase in AFib surgeries due to a large patient pool suffering from cardiovascular diseases uptaking surgical procedures. Substantial growth in medical tourism in Asia has accelerated the number of surgeries conducted in the region, expanding the need for advanced surgical tools and devices. The production aspect of AF surgery is growing in Asia, especially in China and Japan, due to the presence of major medical device manufacturers focusing on developing cost-effective solutions to cater to the ever-growing demand for affordable healthcare services. Europe is another significant market for AFib, with many European-based companies focusing on developing innovative cardiac devices used during AF surgeries. Key players have made substantial investments in research and development activities aimed at advancing surgical technologies for treating atrial fibrillation patients effectively.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Atrial Fibrillation Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Atrial Fibrillation Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.Market Segmentation & Coverage
This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Cardiac Cryoablation Catheters
- Cardiac Mapping System
- Indication
- Atrial Fibrillation (AFib)
- Atrial Flutter
- Supraventricular Tachycardia (SVT)
- End-User
- Cardiology
- Multi Specialities
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Atrial Fibrillation Surgery Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Atrial Fibrillation Surgery Market?
- What are the technology trends and regulatory frameworks in the Atrial Fibrillation Surgery Market?
- What is the market share of the leading vendors in the Atrial Fibrillation Surgery Market?
- Which modes and strategic moves are suitable for entering the Atrial Fibrillation Surgery Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Atrial Fibrillation Surgery Market, by Product
7. Atrial Fibrillation Surgery Market, by Indication
8. Atrial Fibrillation Surgery Market, by End-User
9. Americas Atrial Fibrillation Surgery Market
10. Asia-Pacific Atrial Fibrillation Surgery Market
11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Acesion Pharma ApS
- Acutus Medical, Inc
- Affera, Inc.
- AFreeze GmbH
- Atrian Medical Ltd.
- AtriCure, Inc.
- AuriGen Medical
- BIOTRONIK SE & CO. KG
- Boston Scientific Corporation
- Cardiofocus, Inc.
- CathRx Ltd
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- GE HealthCare Technologies Inc.
- Healium Medical
- Japan Lifeline Co.
- Johnson & Johnson Services, Inc.
- Kardium Inc.
- Koninklijke Philips N.V.
- Medtronic PLC
- OMEICOS Therapeutics GmbH
- Osypka AG
- SentiAR, Inc
- Siemens Healthcare GmbH
- Stryker Corporation
- Terumo Corporation
- Thryv Therapeutics Inc.
- Toray Medical Co., Ltd.
- Vanguard AG
- Volta Medical
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 186 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.9 Billion |
| Forecasted Market Value ( USD | $ 4.88 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
